MarketCatalyst
← Back to Research
Earnings

Ralph Lauren Beats Fiscal Q2 2027 Estimates as Revenue Rises 9.1% to $2.19B

Revenue of $2.19B vs. $2.13B expected and adjusted EPS of $4.64 vs. $4.26; revenue up 9.1% from a year earlier.

Published Nov 5, 2026 · 8:04 AM ET · 2 min read

Ralph Lauren (RL) beat estimates for the fiscal second quarter of 2027 on both revenue and adjusted EPS. Revenue was $2.19 billion, up 9.1% from a year earlier, above the $2.13 billion estimate, and adjusted EPS was $4.64, up 22% from a year earlier, above the $4.26 estimate.

Shares fell 0.5% in premarket trading as of 8:03 a.m. ET, to $410.00 from a $412.06 close.

$4.64
Adjusted EPS, up 22% YoY vs. $4.26 estimate
$2.19B
Revenue, up 9.1% YoY vs. $2.13B estimate
-0.5%
Shares premarket as of 8:03 a.m. ET

Fiscal Q2 2027 scorecard

ParametersExpectedActualBeat/Miss
Adjusted EPS$4.26$4.64Beat by 8.9%
Revenue$2.13B$2.19BBeat by 3.2%
ChangeYoYQoQ
Adjusted EPS▲ 22%▲ 1.1%
Revenue▲ 9.1%▲ 12%

By our calculation, revenue was $67.1 million above the estimate and adjusted EPS was $0.38 above it. The QoQ column compares with the previous quarter's revenue of $1.96 billion and adjusted EPS of $4.59. The YoY column compares with $2.01 billion and $3.79 in the same quarter a year earlier.

Track record

  • EPS record. Adjusted EPS beat the estimate in 8 of the last 8 reports, including this one.
  • Revenue record. Revenue beat the estimate in 8 of the last 8 reports.
  • Revenue trend. Revenue over the last 5 reports, oldest first: $2.01 billion, $2.41 billion, $1.98 billion, $1.96 billion and $2.19 billion.

What to watch

  • Next-quarter estimates. Consensus calls for EPS of $6.90 and revenue of $2.51 billion next quarter, based on 10 analysts.
  • Revenue growth. Whether revenue keeps growing from a year earlier after this quarter's 9.1% increase to $2.19 billion.
  • Estimate record. Whether Ralph Lauren extends a record of beating EPS estimates in 8 of its last 8 reports.
  • Related coverage. See our reports on Novavax, Globalstar, Intellia Therapeutics and Insight Enterprises.

Sources: Results are from Ralph Lauren's Nov. 5, 2026 quarterly report. Estimates are consensus figures. The prior-quarter and year-ago comparison figures are from Ralph Lauren's earlier quarterly reports. Items labeled by our calculation are our own arithmetic. This article is informational only and is not investment advice.

Readers also read

MarketCatalyst is not a registered investment advisor and does not manage client assets. Content on this platform is provided for informational and educational purposes only. It is not investment advice, and MarketCatalyst is not a stock-picking or trade-alert service. Trading stocks and options involves risk, including the possible loss of principal. Consider your own goals, time horizon, and risk tolerance, and consult a qualified financial advisor before making any investment decision.

Ralph Lauren Beats Fiscal Q2 2027 Estimates